Read all posts

Newer Type 2 Diabetes Drugs Show Heart Protective Quality in Study 

A newer class of type 2 diabetes drugs significantly cut the risk of death and hospitalization for heart failure compared with other medicines for the disease, according to data released on Sunday from a so-called real world study sponsored by AstraZeneca.

Read the article on U.S.

Dr. Sears Comments:

Dr. Barry Sears
This article discusses the inhibition of SGLT-2 transport proteins that recapture glucose being dumped into the urine.  However, a better target would be the SGLT-1 proteins at the gut wall that transports glucose in the diet into the blood.  The best inhibitor of this transport protein are purified polyphenol extracts from the maqui berry.

Leave a Reply

Your email address will not be published. Required fields are marked *